Investment
Features
FeesSafety
Academy
More
Pluang+

Compare JPMorgan Chase & Co (JPM) vs Revolution Medicines Inc. Common Stock (RVMD) Price & Performance

JPMorgan Chase & CoTrade
Revolution Medicines Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

JPMorgan Chase & Co vs Revolution Medicines Inc. Common Stock — how do they compare? JPMorgan Chase & Co trades at $332.99 (market cap $880.98B), while Revolution Medicines Inc. Common Stock trades at $189.76 (market cap $40.32B). The key difference: JPMorgan Chase & Co is far larger — about 21.8× Revolution Medicines Inc. Common Stock's market cap, and JPMorgan Chase & Co pays a 1.99% dividend while Revolution Medicines Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold JPMorgan Chase & Co for 127 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.

JPMRVMD
Market Cap
$880.98B$40.32B
Volume
7,721,6614,855,734
Sector
FinancialsHealth
52-Week High
$365.18$221.15
52-Week Low
$282.84$47.50
Typical Hold Time
127 Days0 Days
Enterprise Value
$1.82T$37.02B
Dividend Yield
1.99%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

JPMorgan Chase & Co

JPMorgan Chase (JPM) trades at $332.99, up 1.03% today, with a bearish technical signal but strong fundamentals. Recent earnings beat expectations in Q1 and Q2 2026, with revenue growth from $181.85B in 2025 to a projected $194.9B in 2026. The stock shows a P/E of 14.2 and ROE of 18.43%, supported by a 'Moderate Buy' analyst consensus and a $373.18 price target. News highlights CEO Jamie Dimon's economic warnings and upcoming Q1 earnings as key catalysts.

Outlook: JPM offers value with solid profitability and analyst upside, but risks include geopolitical tensions and cybersecurity threats. The stock's bearish technicals near support at $327 suggest caution, though institutional buying and high ROE provide stability. Investors should weigh strong fundamentals against macroeconomic headwinds highlighted in recent news.

Revolution Medicines Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

JPM
30% Buy70% Sell
Avg holding period · 127 Days
RVMD
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About JPMorgan Chase & Co

JPMorgan Chase & Co. provides global financial services and retail banking. The Company provides services such as investment banking, treasury and securities services, asset management, private banking, card member services, commercial banking, and home finance. JP Morgan Chase serves business enterprises, institutions, and individuals.

Read more on JPM →

About Revolution Medicines Inc. Common Stock

Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.

Read more on RVMD →